Partner with us on your next clinical study.

For over fifty years, Celerion has leveraged the latest operational concepts and technologies to execute safety/tolerability, pharmacokinetic, and pharmacodynamic studies in highly controlled clinical environments. These include first-in-human dose escalation, drug-drug interaction, cardiac safety, bioequivalence and bioavailability, metabolism, and excretion studies, as well as pharmacokinetic evaluations in patients with impaired renal or hepatic function.

On site at our clinics, we also provide bioanalysis for small and large molecules (for pre-clinical and human studies). Our full-service offering includes protocol design, data management, monitoring, PK/statistical analysis, and regulatory strategy. We also have extensive partner site relationships for your small patient studies.

Let us share our experience as you plan your next clinical study.